CR6983A - HISTAMINE RECEIVER ANTAGONISTS - Google Patents

HISTAMINE RECEIVER ANTAGONISTS

Info

Publication number
CR6983A
CR6983A CR6983A CR6983A CR6983A CR 6983 A CR6983 A CR 6983A CR 6983 A CR6983 A CR 6983A CR 6983 A CR6983 A CR 6983A CR 6983 A CR6983 A CR 6983A
Authority
CR
Costa Rica
Prior art keywords
histamine
receiver
histamine receiver
receiver antagonists
antagonists
Prior art date
Application number
CR6983A
Other languages
Spanish (es)
Inventor
Jenkinson Stephen
Anthony O'reilly Mark
Andrew Trevethick Michael
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CR6983A publication Critical patent/CR6983A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UNA COMBINACION DE (A) UN ANTAGONISTA DE RECEPTOR H1 DE HISTAMINA Y (B) UN ANTAGONISTA QUE ES AL MENOS 10 VECES MAS SELECTIVO PARA EL RECEPTOR H4 DE HISTAMINA EN COMPARACION CON EL RECEPTOR H3 DE HISTAMINA, Y UN ANTAGONISTA QUE ES AL MENOS 10 VECES MAS SELECTIVO PARA EL RECEPTOR H4 DE HISTAMINA EN COMPARACION CON EL RECEPTOR H3 DE HISTAMINA Y SUS COMPOSICIONES Y USOS.THIS INVENTION PROVIDES A COMBINATION OF (A) AN HISTAMINE RECEIVER ANTAGONIST AND (B) AN ANTAGONIST THAT IS AT LEAST 10 TIMES MORE SELECTIVE FOR HISTAMINE RECEIVER H4, COMPARED TO HISTAMINE RECEIVER, AND AN ANTAGON IT IS AT LEAST 10 TIMES MORE SELECTIVE FOR THE H4 HISTAMINE RECEIVER COMPARED TO THE HISTAMINE H3 RECEIVER AND ITS COMPOSITIONS AND USES.

CR6983A 2001-01-17 2003-05-22 HISTAMINE RECEIVER ANTAGONISTS CR6983A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
CR6983A true CR6983A (en) 2003-11-25

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6983A CR6983A (en) 2001-01-17 2003-05-22 HISTAMINE RECEIVER ANTAGONISTS

Country Status (31)

Country Link
EP (1) EP1353657A1 (en)
JP (1) JP2004517883A (en)
KR (1) KR20030069216A (en)
CN (1) CN1486178A (en)
AP (1) AP2002002401A0 (en)
AR (1) AR032101A1 (en)
BG (1) BG107834A (en)
BR (1) BR0206502A (en)
CA (1) CA2435121A1 (en)
CR (1) CR6983A (en)
CZ (1) CZ20031853A3 (en)
DO (1) DOP2002000325A (en)
EA (1) EA200300537A1 (en)
EC (1) ECSP034692A (en)
EE (1) EE200300335A (en)
GB (1) GB0101223D0 (en)
GT (1) GT200200003A (en)
HU (1) HUP0302767A2 (en)
IL (1) IL156087A0 (en)
IS (1) IS6818A (en)
MA (1) MA26980A1 (en)
MX (1) MXPA03006408A (en)
NO (1) NO20033223L (en)
OA (1) OA12440A (en)
PA (1) PA8537101A1 (en)
PL (1) PL362793A1 (en)
SK (1) SK8572003A3 (en)
SV (1) SV2003000849A (en)
TN (1) TNSN02003A1 (en)
WO (1) WO2002056871A2 (en)
ZA (1) ZA200304180B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
WO2004021999A2 (en) * 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. Use of histamine h4 receptor modulators for the treatment of allergy and asthma
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP3378476A1 (en) 2012-06-08 2018-09-26 Sensorion H4 receptor inhibitors for treating tinnitus

Also Published As

Publication number Publication date
BR0206502A (en) 2003-10-21
SV2003000849A (en) 2003-01-13
NO20033223D0 (en) 2003-07-16
TNSN02003A1 (en) 2005-12-23
PL362793A1 (en) 2004-11-02
HUP0302767A2 (en) 2003-11-28
OA12440A (en) 2006-05-22
EA200300537A1 (en) 2004-02-26
EP1353657A1 (en) 2003-10-22
ECSP034692A (en) 2003-08-29
EE200300335A (en) 2003-12-15
GB0101223D0 (en) 2001-02-28
MXPA03006408A (en) 2003-10-15
PA8537101A1 (en) 2002-08-29
ZA200304180B (en) 2004-06-15
CN1486178A (en) 2004-03-31
JP2004517883A (en) 2004-06-17
NO20033223L (en) 2003-07-16
IL156087A0 (en) 2003-12-23
BG107834A (en) 2004-01-30
GT200200003A (en) 2002-08-19
CA2435121A1 (en) 2002-07-25
AP2002002401A0 (en) 2002-03-31
IS6818A (en) 2003-05-15
KR20030069216A (en) 2003-08-25
AR032101A1 (en) 2003-10-22
SK8572003A3 (en) 2004-07-07
CZ20031853A3 (en) 2004-07-14
DOP2002000325A (en) 2003-01-31
WO2002056871A2 (en) 2002-07-25
MA26980A1 (en) 2004-12-20

Similar Documents

Publication Publication Date Title
PA8567001A1 (en) ZIPRASIDONE COMPOSITION AND SYNTHETIC CONTROLS
PA8527201A1 (en) CYCLED PEPTIDES WITH AGONIST ACTIVITY FOR THE RECEIVER OF MELANOCORTIN-4 (MC4-R)
DK1328269T4 (en) Combination of a CB1 receptor antagonist and sibutramine for the treatment of obesity
CY1108649T1 (en) Substituted arylpyrazoles as pesticides
DK1379239T3 (en) N (2-aryl-ethyl) -benzylamines as antagonists of the HT6 receptor
DK1300398T3 (en) Propane-1,3-dione derivative
HN2002000299A (en) DERIVATIVES OF 3- AZABICICLO [3.1.0] HEXANO
BR0206595A (en) Compound, pharmaceutical composition, and use of a compound
NO993350L (en) Vitronectin receptor antagonists
CR6983A (en) HISTAMINE RECEIVER ANTAGONISTS
SV2004001250A (en) MUSCARINIC AGONISTS REF, X - 15335
BR0312378A (en) Cck-1 Receiver Modulators
UY26627A1 (en) IL-8 RECEPTOR ANTAGONISTS
SV2003001179A (en) FORMULATION OF 2-METHYL-TIENO-BENZODIACEPIN LIOFILIZED REF. X-11102
UY27124A1 (en) HISTAMINE RECEIVER ANTAGONISTS
DK1177191T3 (en) Substituted benzimidazoles, preparation and use thereof as agents for the control of parasitic protozoa
HN2002000348A (en) PHARMACEUTICAL COMBINATION
IS7539A (en) Self-dispensing contraceptives from an oily solution.
HN2002000355A (en) PHARMACEUTICAL COMBINATION
DK1420789T3 (en) Use of active substances with myopioid receptor agonist and opioid receptor antagonist effect as combination drugs for cancer treatment
HN2002000356A (en) PHARMACEUTICAL COMBINATION
ATE328595T1 (en) CARVEDILOL POLYMORPHOUS
DE50304218D1 (en) SANITARY CABIN
ES1050208Y (en) FOOTWEAR ADAPTER FOR MOTORCYCLING.
HN2000000084A (en) METALOPROTEASE INHIBITORS.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)